FDA recall record

Us Endovascular USE (Ebony) PTA .014" rapid exchange (RX) Peripheral Dilatation Catheter recall — FDA Z-1362-2016

Product may kink during use rendering the product unusable.

Class IIclassification
Z-1362-2016official record ID
Apr 20, 2016report date

Recall record at a glance

Official recordZ-1362-2016
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmUs Endovascular
Report dateApr 20, 2016
Recall initiation dateFeb 11, 2016
Quantity843 catheters
LocationSaint Louis, MO, United States

Official product description

USE (Ebony) PTA .014" rapid exchange (RX) Peripheral Dilatation Catheter. Distributed by US Endovascular, St. Louis, MO.

Why the product was recalled

Product may kink during use rendering the product unusable.

Distribution information

US Distribution to the states of : AR, CA, FL, LA, MO, MI, MS, NY, TN, and TX.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.